85 related articles for article (PubMed ID: 11038754)
1. [Inhibition of angiogenesis with antisense ODN of VEGF].
Dong F; Jin Y
Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):264-6. PubMed ID: 11038754
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
Wood JM
Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930
[TBL] [Abstract][Full Text] [Related]
3. [Effects of VEGF-A/VEGF-C antisense oligodeoxynucleotide on angiogenesis, lymphangiogenesis, and tumor growth of breast cancer].
Chen JS; Zhang YJ; Hu SE; Zhang HQ
Ai Zheng; 2007 Sep; 26(9):972-6. PubMed ID: 17927855
[TBL] [Abstract][Full Text] [Related]
4. [Inhibition of K562 cell growth and tumor angiogenesis in nude mice by antisense VEGF(121) cDNA transfection].
Ruan G; Liu Y; Chen S; Qin Y; Li J; Fu J; Yu H; Chang Y
Zhonghua Xue Ye Xue Za Zhi; 2002 Apr; 23(4):179-82. PubMed ID: 12133452
[TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment of angiogenesis and tumor vessel architecture by computer-assisted digital image analysis: effects of VEGF-toxin conjugate on tumor microvessel density.
Wild R; Ramakrishnan S; Sedgewick J; Griffioen AW
Microvasc Res; 2000 May; 59(3):368-76. PubMed ID: 10792968
[TBL] [Abstract][Full Text] [Related]
6. Anti-VEGF antibody in experimental hepatoblastoma: suppression of tumor growth and altered angiogenesis.
McCrudden KW; Hopkins B; Frischer J; Novikov A; Huang J; Kadenhe A; New T; Yokoi A; Yamashiro DJ; Kandel JJ; Middlesworth W
J Pediatr Surg; 2003 Mar; 38(3):308-14; discussion 308-14. PubMed ID: 12632340
[TBL] [Abstract][Full Text] [Related]
7. [Effect of PCNA antisense oligooxynucleotides and VEGF antisense oligoxynucleotides on growth of hepatocellular carcinoma transplanted in nude mice].
Zhu J; Huang J; Chen Y
Zhonghua Wai Ke Za Zhi; 2001 Nov; 39(11):875-7. PubMed ID: 11930748
[TBL] [Abstract][Full Text] [Related]
8. [Inhibitation of tumor angiogenesis, growth and metastasis by blocking VEGF paracrine pathway].
Wang F; Tian YH; Li L; Chen XF; Hu HH; Li CY; Huang Q
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Mar; 34(2):165-70. PubMed ID: 12006990
[TBL] [Abstract][Full Text] [Related]
9. Suppression of ganglioside GD3 expression in a rat F-11 tumor cell line reduces tumor growth, angiogenesis, and vascular endothelial growth factor production.
Zeng G; Gao L; Birklé S; Yu RK
Cancer Res; 2000 Dec; 60(23):6670-6. PubMed ID: 11118051
[TBL] [Abstract][Full Text] [Related]
10. Neutralizing vascular endothelial growth factor activity inhibits thyroid cancer growth in vivo.
Soh EY; Eigelberger MS; Kim KJ; Wong MG; Young DM; Clark OH; Duh QY
Surgery; 2000 Dec; 128(6):1059-65;discussion 1065-6. PubMed ID: 11114643
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
Middeke M; Hoffmann S; Hassan I; Wunderlich A; Hofbauer LC; Zielke A
Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):386-92. PubMed ID: 12518248
[TBL] [Abstract][Full Text] [Related]
12. [Experimental study of anti-vascular endothelial growth factor hairpin ribozyme gene inhibiting growth of xenografted tumor of ovarian cancer cells].
Yan R; Xin X; Jin M; Hui H; Wang J; Wang D
Zhonghua Fu Chan Ke Za Zhi; 2002 Nov; 37(11):683-6. PubMed ID: 12487926
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma.
Yoshiji H; Kuriyama S; Yoshii J; Ikenaka Y; Noguchi R; Hicklin DJ; Huber J; Nakatani T; Tsujinoue H; Yanase K; Imazu H; Fukui H
Hepatology; 2002 Apr; 35(4):834-42. PubMed ID: 11915029
[TBL] [Abstract][Full Text] [Related]
14. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
[TBL] [Abstract][Full Text] [Related]
15. [Effects on lymphangiogenesis and angiogenesis of lung cancer with antisense oligonucleotides of vascular endothelial growth factor C].
Guo XF; Xu ZH; Chen YB; Xu ZH; Yang WT; Qian YY; Hu GQ
Zhonghua Wai Ke Za Zhi; 2008 May; 46(9):694-6. PubMed ID: 18956726
[TBL] [Abstract][Full Text] [Related]
16. EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migration.
Riedel F; Götte K; Li M; Hörmann K; Grandis JR
Int J Oncol; 2002 Jul; 21(1):11-6. PubMed ID: 12063543
[TBL] [Abstract][Full Text] [Related]
17. The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor.
Yoshiji H; Kuriyama S; Kawata M; Yoshii J; Ikenaka Y; Noguchi R; Nakatani T; Tsujinoue H; Fukui H
Clin Cancer Res; 2001 Apr; 7(4):1073-8. PubMed ID: 11309359
[TBL] [Abstract][Full Text] [Related]
18. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
Cheng N; Brantley DM; Liu H; Lin Q; Enriquez M; Gale N; Yancopoulos G; Cerretti DP; Daniel TO; Chen J
Mol Cancer Res; 2002 Nov; 1(1):2-11. PubMed ID: 12496364
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor.
Guba M; von Breitenbuch P; Steinbauer M; Koehl G; Flegel S; Hornung M; Bruns CJ; Zuelke C; Farkas S; Anthuber M; Jauch KW; Geissler EK
Nat Med; 2002 Feb; 8(2):128-35. PubMed ID: 11821896
[TBL] [Abstract][Full Text] [Related]
20. VEGF-mediated angiogenesis of human pheochromocytomas is associated to malignancy and inhibited by anti-VEGF antibodies in experimental tumors.
Zielke A; Middeke M; Hoffmann S; Colombo-Benkmann M; Barth P; Hassan I; Wunderlich A; Hofbauer LC; Duh QY
Surgery; 2002 Dec; 132(6):1056-63; discussion 1063. PubMed ID: 12490855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]